Market News

Latest financial and economic news and analysis

GlobeNewsWire News Agency
22 hours agoGlobeNewsWire
Stocks Medium Importance Neutral
MSFT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Microsoft Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – MSFT

MSFT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Microsoft Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – MSFT

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Microsoft Corporation (NASDAQ: MSFT) between May 1, 2025 and January 28, 2026, inclusive (the “Class Period”), of the important August 11, 2026 lead plaintiff deadline.

Source: GlobeNewsWire
Visit Source
Comment
Newsfile Corp News Agency
22 hours agoNewsfile Corp
Stocks Medium Importance Neutral
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

New York, New York--(Newsfile Corp. - August 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.

Related Symbols 1
LAW LAW
Source: Newsfile Corp
Visit Source
Comment
CNBC News Agency
22 hours agoCNBC
Stocks Medium Importance Neutral
Copper jumps to its highest level ever. What the metal is telling us

Copper jumps to its highest level ever. What the metal is telling us

Copper hit a record high, but the rally appears to reflect tight supply and disruptions more than a broad acceleration in global growth. Electrification, power-grid investment and AI-related infrastructure are supporting demand.

Related Symbols 1
CPER CPER
Source: CNBC
Visit Source
Comment
GlobeNewsWire News Agency
22 hours agoGlobeNewsWire
Stocks Medium Importance Neutral
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Datavault AI Inc. (DVLT)

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Datavault AI Inc. (DVLT)

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania on behalf of all persons or entities who purchased or otherwise acquired Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ: DVLT) securities between September 4, 2024 and October 30, 2025, inclusive (the “Class Period”).

Related Symbols 1
DVLT DVLT
Source: GlobeNewsWire
Visit Source
Comment
Reuters News Agency
23 hours agoReuters
Stocks Medium Importance Neutral
Iraq's KRG says Dana Gas, Crescent Petroleum breached contract over Khor Mor gas supplies

Iraq's KRG says Dana Gas, Crescent Petroleum breached contract over Khor Mor gas supplies

Iraq's Kurdistan Regional ​Government (KRG) said on Thursday that Dana Gas and Crescent Petroleum had breached their contractual obligations ‌by starting natural gas supplies from the Khor Mor field to Iraq's electricity ministry without its approval.

Related Symbols 1
KRG KRG
Source: Reuters
Visit Source
Comment
Proactive Investors News Agency
23 hours agoProactive Investors
Stocks Medium Importance Neutral
Apple App Store revenue ticks up despite falling downloads

Apple App Store revenue ticks up despite falling downloads

Apple Inc (NASDAQ:AAPL, XETRA:APC) App Store revenue rose 0.6% year-over-year in the first 35 days of its fiscal fourth quarter to $3.4 billion, up from $3.38 billion in the same period last year, according to a note from Bank of America. Total downloads across iPhone and iPad fell 4% year-over-year to 3.3 billion over the same stretch, while App Store dollars per download climbed 4.7% to $1.02, BofA said, citing data from SensorTower.

Related Symbols 1
Source: Proactive Investors
Visit Source
Comment
GlobeNewsWire News Agency
23 hours agoGlobeNewsWire
Stocks Medium Importance Neutral
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons or entities who purchased or otherwise acquired ARS Pharmaceuticals Inc. (ARS Pharm. or the “Company”) (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026, inclusive (the “Class Period”).

Related Symbols 1
SPRY SPRY
Source: GlobeNewsWire
Visit Source
Comment
Newsfile Corp News Agency
23 hours agoNewsfile Corp
Stocks Medium Importance Neutral
Kaplan Fox & Kilsheimer LLP Alerts ARS Pharmaceuticals Inc. (SPRY) Investors to a Securities Class Action Deadline on October 5, 2026

Kaplan Fox & Kilsheimer LLP Alerts ARS Pharmaceuticals Inc. (SPRY) Investors to a Securities Class Action Deadline on October 5, 2026

New York, New York--(Newsfile Corp. - August 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against ARS Pharmaceuticals Inc. ("ARS" or the "Company") (NASDAQ: SPRY) on behalf of investors that purchased or otherwise acquired ARS securities between March 9, 2026 and June 24, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in ARS and have suffered losses, you may CLICK HERE to contact us.

Related Symbols 1
SPRY SPRY
Source: Newsfile Corp
Visit Source
Comment
Zacks Investment Research News Agency
23 hours agoZacks Investment Research
Stocks Medium Importance Neutral
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?

Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?

AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.

Related Symbols 1
ANGO ANGO
Source: Zacks Investment Research
Visit Source
Comment